FDA
-
-
-
-
-
-
-
Adagene partners with Incyte for cancer drug combination study
-
-
-
-
-
-
-
Adagene to Participate in Two Upcoming Investor Conferences
-
-
-
-
-
-
-
Adagene Appoints Immuno-Oncology Pioneer, Axel Hoos, M.D., Ph.D., as Executive Advisor
-
-
-
-
-
-
-
Adagene (ADAG) Announces Progress and Expansion of Clinical Collaboration Program for ADG126 in Combination with KEYTRUDA
-
-
-
-
-
-
-
Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4 SAFEbody® ADG126 in Combination with Roche’s Standard-of-Care for First-Line Advanced Liver Cancer
-
-
-
-
-
-
-
Pre-Open Stock Movers 11/30: (CPIX) (IMGN) (VIR) Higher; (JKS) (LIZI) (SEDG) Lower (more...)
-
-
-
-
-
-
-
Adagene Announces Appointment of Interim Chief Medical Officer and New Members of Scientific and Strategic Advisory Board
-
322,969 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

